Lupin Receives China Approval For Oseltamivir Phosphate Oral Suspension

(MENAFN - PR Newswire) Marks Lupin's Debut in the Chinese Market MUMBAI, India and BEIJING, May 22, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) ...